首页 | 本学科首页   官方微博 | 高级检索  
     

阿昔洛韦片体内生物利用度研究
引用本文:童荣生,何林,孙世明,吴正中. 阿昔洛韦片体内生物利用度研究[J]. 西北药学杂志, 2001, 16(2): 70-71
作者姓名:童荣生  何林  孙世明  吴正中
作者单位:四川省人民医院临床药理研究室
摘    要:研究两种阿昔洛韦片药物动力学及生物等效性。采用反相高效液相色谱法 ( C18柱 ,流动相为 0 .1%醋酸溶液 ,流速 1.4 ml/min,测定波长 2 54nm)测定 10名志愿受试者单剂量口服 60 0 mg阿昔洛韦片后 ,阿昔洛韦血药浓度变化情况。结果表明供试品和参比制剂为生物等效制剂。药时曲线下面积分别是 :5.30± 1.19(μg· h) /ml与 5.4 1± 1.34 ( μg· h) /ml,达峰时间分别为 :1.84± 0 .55h与 1.97± 0 .39h,峰浓度分别是 :1.0 9± 0 .18μg/ml与 1.0 6± 0 .2 2 μg/ml。

关 键 词:阿昔洛韦  药代动力学  生物利用度  片剂
修稿时间:2000-10-13

Study on relativebioavailability of acyclovir tablets in healthy volunteers
Tong Rongsheng,He Lin,Sun Shiming,Wu Zhengzhong. Study on relativebioavailability of acyclovir tablets in healthy volunteers[J]. Northwest Pharmaceutical Journal, 2001, 16(2): 70-71
Authors:Tong Rongsheng  He Lin  Sun Shiming  Wu Zhengzhong
Abstract:The pharmacokinetics and relative bioavailability of two kinds of acyclovir tablets were studied. Acyclovir concentration in the plasma was detected by RP-HPLC after taken orally 600mg of acyclovir tablets respectively by 10 volunteers according an open randomized cross-over test. The results showed that the AUC0→∞ of acyclovir of the two formulations were(5.30±1.19)μg*h/ml and (5.41±1.34)μg*h/ml;Tmax were(1.84±0.55)h and (1.97±0.39)h; Cmax were(1.09±0.18)μg/ml and (1.06±0.22)μg/ml respectively. The statistical analysis demonstrated two kinds of acycolvir tablets were bioequivalent.
Keywords:acyclovir   pharmacokinetics   bioavailability   tablets
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号